These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6879000)

  • 1. Herd immunity and measles.
    Fox JP
    Rev Infect Dis; 1983; 5(3):463-6. PubMed ID: 6879000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles: summary of worldwide impact.
    Assaad F
    Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measles control in developing countries].
    Cutts FT; Dabis F
    Sante; 1994; 4(3):163-71. PubMed ID: 7921681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of measles in highly immunized populations. A modeling approach.
    Levy DL
    Am J Epidemiol; 1984 Jul; 120(1):39-48. PubMed ID: 6741921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: an agent-based simulation for California.
    Liu F; Enanoria WT; Zipprich J; Blumberg S; Harriman K; Ackley SF; Wheaton WD; Allpress JL; Porco TC
    BMC Public Health; 2015 May; 15():447. PubMed ID: 25928152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the Number of Measles-Susceptible Children and Adolescents in the United States Using Data From the National Immunization Survey-Teen (NIS-Teen).
    Bednarczyk RA; Orenstein WA; Omer SB
    Am J Epidemiol; 2016 Jul; 184(2):148-56. PubMed ID: 27338281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum attack rate for measuring measles vaccine efficacy.
    Nourjah P; Frerichs RR
    Int J Epidemiol; 1995 Aug; 24(4):834-41. PubMed ID: 8550283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating contact-adjusted immunity levels against measles in South Korea and prospects for maintaining elimination status.
    Chun JY; Park WB; Kim NJ; Choi EH; Funk S; Oh MD
    Vaccine; 2020 Jan; 38(2):107-111. PubMed ID: 31679860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.
    Anderson RM; May RM
    J Hyg (Lond); 1985 Jun; 94(3):365-436. PubMed ID: 4008922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness.
    Murray M; Rasmussen Z
    Am J Epidemiol; 2000 Apr; 151(8):811-9. PubMed ID: 10965978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles in Mexico.
    Fernandez de Castro J
    Rev Infect Dis; 1983; 5(3):422-6. PubMed ID: 6878993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles in England and Wales--II: The impact of the measles vaccination programme on the distribution of immunity in the population.
    Fine PE; Clarkson JA
    Int J Epidemiol; 1982 Mar; 11(1):15-25. PubMed ID: 7085174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study.
    Glasser JW; Feng Z; Omer SB; Smith PJ; Rodewald LE
    Lancet Infect Dis; 2016 May; 16(5):599-605. PubMed ID: 26852723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles outbreak in the Republic of the Marshall Islands, 2003.
    Hyde TB; Dayan GH; Langidrik JR; Nandy R; Edwards R; Briand K; Konelios M; Marin M; Nguyen HQ; Khalifah AP; O'leary MJ; Williams NJ; Bellini WJ; Bi D; Brown CJ; Seward JF; Papania MJ
    Int J Epidemiol; 2006 Apr; 35(2):299-306. PubMed ID: 16299123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population profile of measles susceptibility in Tianjin, China.
    Boulton ML; Wang X; Zhang Y; Montgomery JP; Wagner AL; Carlson BF; Ding Y; Li X; Gillespie B; Su X
    Vaccine; 2016 Jun; 34(27):3037-3043. PubMed ID: 27151881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the Population Susceptibility Against Measles in Slovakia.
    Zibolenová J; Chladná Z; Švihrová V; Baška T; Waczulíková I; Hudečková H
    Cent Eur J Public Health; 2017 Mar; 25(1):46-54. PubMed ID: 28399355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The largest outbreak of measles in the United States during 1999: imported measles and pockets of susceptibility.
    Rooney JA; Milton DJ; Hackler RL; Harris JH; Reynolds D; Tanner M; Taylor E
    J Infect Dis; 2004 May; 189 Suppl 1():S78-80. PubMed ID: 15106093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.